Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech

Loading...
Loading...

On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options volume in SPDR S&P Biotech (ETF) XBI.

He said that around 22,000 contracts of the November 90 calls were bought for $2. It's unusual to see that much volume in SPDR S&P Biotech, explained Najarian. The trade breaks even at $92 or 4.26 percent above the current market price. Najarian decided to follow the trade.

Posted In: CNBCOptionsMarketsMediaETFsFast Money Halftime ReportPete Najarian
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...